Delta-9-tetrahydrocannabinol accumulation, metabolism and cell-type-specific adverse effects in aggregating brain cell cultures
- 1 April 2008
- journal article
- Published by Elsevier BV in Toxicology and Applied Pharmacology
- Vol. 228 (1), 8-16
- https://doi.org/10.1016/j.taap.2007.11.007
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Cannabinoid receptors in microglia of the central nervous system: immune functional relevanceJournal of Leukocyte Biology, 2005
- The endocannabinoid system: a general view and latest additionsBritish Journal of Pharmacology, 2004
- The therapeutic potential of cannabisThe Lancet Neurology, 2003
- Therapeutic Action of Cannabinoids in a Murine Model of Multiple SclerosisJournal of Neuroscience, 2003
- Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activationInternational Immunopharmacology, 2001
- Endocannabinoids control spasticity in a multiple sclerosis modelThe FASEB Journal, 2000
- Cannabinoids control spasticity and tremor in a multiple sclerosis modelNature, 2000
- Dexanabinol (HU-211) effect on experimental autoimmune encephalomyelitis: implications for the treatment of acute relapses of multiple sclerosisJournal of Neuroimmunology, 2000
- Hippocampal Neurotoxicity of Δ9-TetrahydrocannabinolJournal of Neuroscience, 1998
- Influence of fatty acid ethanolamides and Δ9-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cellsEuropean Journal of Pharmacology, 1997